Latest News and Press Releases

George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US An innovative single pill...

Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Cardiac Amyloidosis Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been...

Palo Alto, CA, July 10, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced their support for...

Novel, single pill, triple combination with a standard dose and two lower doses that can deliver the efficacy benefits of combination therapy, with an established safety profile and good...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Acute Ischemic Stroke Market - A Global and Regional Analysis: Focus on Therapeutics, and Regional Analysis - Analysis and Forecast, 2025-2035" report...

-       Successful track record in the commercialization of biopharmaceutical products as well as strategic advisory in orphan diseases Kiel, Germany, May 21, 2025 – tiakis Biotech AG, a...

Teladoc Health's new offering is designed to support optimal cardiometabolic health for all populations and prevent the progression of disease.

George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs London, UK, 3 February 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing...

Palo Alto, CA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced that the Centers...

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central AmericaBausch Health gains exclusive rights to single-pill triple...